Press release: Filing of the 2025 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial Report

Core Insights - Sanofi has filed its Form 20-F with the U.S. SEC and its "Document d'Enregistrement Universel" with the French AMF, which includes the Annual Financial Report [1] - These documents contain complete audited financial statements and are available on the company's website as well as the SEC and AMF websites [1] Company Overview - Sanofi is an R&D driven, AI-powered biopharma company focused on improving lives and fostering growth through innovative medicines and vaccines [2] - The company leverages its understanding of the immune system to develop treatments that benefit millions globally, with a commitment to addressing urgent healthcare, environmental, and societal challenges [2] - Sanofi is publicly traded on EURONEXT under the ticker SAN and on NASDAQ under the ticker SNY [2]